OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
Florine E. M. Scholte, Ercan Karaaslan, Justin T. O’Neal, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Florine E. M. Scholte, Ercan Karaaslan, Justin T. O’Neal, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Showing 11 citing articles:
Interventions for the control of Crimean-Congo hemorrhagic fever and tick vectors
José de la Fuente, S. Ghosh, Laetitia Lempereur, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
José de la Fuente, S. Ghosh, Laetitia Lempereur, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses
Eva Calvo-Pinilla, Sandra Moreno, Natalia Barreiro-Piñeiro, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 291-291
Open Access
Eva Calvo-Pinilla, Sandra Moreno, Natalia Barreiro-Piñeiro, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 291-291
Open Access
Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19–21, 2023
Stephen R. Welch, Aura R. Garrison, Dennis A. Bente, et al.
Antiviral Research (2024) Vol. 225, pp. 105844-105844
Closed Access | Times Cited: 4
Stephen R. Welch, Aura R. Garrison, Dennis A. Bente, et al.
Antiviral Research (2024) Vol. 225, pp. 105844-105844
Closed Access | Times Cited: 4
Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus
Teresa E. Sorvillo, Elif Karaaslan, Florine E. M. Scholte, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Teresa E. Sorvillo, Elif Karaaslan, Florine E. M. Scholte, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice
Elif Karaaslan, Teresa E. Sorvillo, Florine E. M. Scholte, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Elif Karaaslan, Teresa E. Sorvillo, Florine E. M. Scholte, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Cellular immunity to nucleoproteins (NP) of Crimean-Congo hemorrhagic fever virus (CCHFV) and Hazara Virus (HAZV)
Merve Kalkan-Yazıcı, Elif Karaaslan, Nesibe Selma Güler-Çetin, et al.
Medical Microbiology and Immunology (2024) Vol. 213, Iss. 1
Closed Access | Times Cited: 1
Merve Kalkan-Yazıcı, Elif Karaaslan, Nesibe Selma Güler-Çetin, et al.
Medical Microbiology and Immunology (2024) Vol. 213, Iss. 1
Closed Access | Times Cited: 1
The Role of Nucleocapsid Protein (NP) in the Immunology of Crimean–Congo Hemorrhagic Fever Virus (CCHFV)
Aysegul Pirincal, Mehmet Ziya Doymaz
Viruses (2024) Vol. 16, Iss. 10, pp. 1547-1547
Open Access
Aysegul Pirincal, Mehmet Ziya Doymaz
Viruses (2024) Vol. 16, Iss. 10, pp. 1547-1547
Open Access
Rapid, Sensitive, and Species-Independent Detection of Crimean Congo Hemorrhagic Fever Virus Nucleoprotein and GP38 Antibodies
Elif Karaaslan, Cheng‐Feng Chiang, Gülter Öncü Kurutaş, et al.
(2024)
Closed Access
Elif Karaaslan, Cheng‐Feng Chiang, Gülter Öncü Kurutaş, et al.
(2024)
Closed Access
Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaques
Alyssa Kleymann, Elif Karaaslan, Florine E. M. Scholte, et al.
Antiviral Research (2024), pp. 106045-106045
Closed Access
Alyssa Kleymann, Elif Karaaslan, Florine E. M. Scholte, et al.
Antiviral Research (2024), pp. 106045-106045
Closed Access
Crimean-Congo haemorrhagic fever (CCHF): present and future therapeutic armamentarium
Stefano Di Bella, Stella Babich, Roberto Luzzati, et al.
Infezioni in Medicina (2024) Vol. 4, Iss. 32
Closed Access
Stefano Di Bella, Stella Babich, Roberto Luzzati, et al.
Infezioni in Medicina (2024) Vol. 4, Iss. 32
Closed Access
Reverse Genetics System for Crimean-Congo Hemorrhagic Fever Virus
Florine E. M. Scholte, Elif Karaaslan, Éric Bergeron
Methods in molecular biology (2024), pp. 247-256
Closed Access
Florine E. M. Scholte, Elif Karaaslan, Éric Bergeron
Methods in molecular biology (2024), pp. 247-256
Closed Access
Replicating RNA vaccine confers durable immunity against Crimean Congo hemorrhagic fever virus challenge in mice
Shanna Leventhal, Carl Shaia, Deepashri Rao, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Shanna Leventhal, Carl Shaia, Deepashri Rao, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
